Impact of pharmacodynamic variability on drug delivery1
- 7 September 1998
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 33 (3) , 201-206
- https://doi.org/10.1016/s0169-409x(98)00028-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Population Pharmacodynamics: Strategies for Concentration- and Effect-Controlled Clinical TrialsAnnals of Pharmacotherapy, 1996
- Feasibility of Effect-Controlled Clinical Trials of Drugs with Pharmacodynamic Hysteresis Using Sparse DataPharmaceutical Research, 1996
- Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam*Clinical Pharmacology & Therapeutics, 1995
- Concentration- or effect-controlled clinical trials with sparse dataClinical Pharmacology & Therapeutics, 1994
- Pharmacodynamic variability of flecainide assessed by QRS changesClinical Pharmacology & Therapeutics, 1993
- Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamicsJournal of Pharmacokinetics and Biopharmaceutics, 1991
- Time and concentration related cardiovascular effects of xamoterol in healthy volunteers at restEuropean Journal of Pharmacology, 1990
- Dose-Plasma Concentration-Effect Relationship of Felodipine in Essential HypertensionJournal of Cardiovascular Pharmacology, 1990
- Blood disoprofol levels in anaesthetised patientsAnaesthesia, 1982
- Kinetics of pharmacologic effectsClinical Pharmacology & Therapeutics, 1966